Biohaven Pharmaceutical Holding Co Ltd. 4/A SEC Filings

Filed On	Filing
11 Feb 2022	Form 4/A: Doogan Declan, Director Sold 15,798 shares ($1.08M) · Sold 25,508 shares ($1.75M)
11 Feb 2022	Form 4/A: Doogan Declan, Director Sold 25,039 shares ($1.62M) · Sold 25,914 shares ($1.7M)
26 Nov 2021	Form 4/A: Conway Charles, Chief Scientific Officer Granted 42,612 Employee Stock Option (Right to Buy)
26 Mar 2021	Form 4/A: Heffernan Michael Thomas, Director Granted 26,200 Stock Option (right to buy) · Granted 0 Stock Option (Right to Buy)
26 Mar 2021	Form 4/A: Hugin Robert J, Director Granted 18,948 Stock Options (Right to buy)
20 Jun 2018	Form 4/A: Berman Robert, Chief Medical Officer Sold 60,416 shares ($2.18M) · Sold 16,276 shares ($609K)
11 May 2018	Form 4/A: Engelhart James, Chief Financial Officer Exercised 8,400 Employee Stock Option (Right to Buy)
25 Jan 2018	Form 4/A: Portage Biotech Inc., former 10% owner Sold 35,119 shares ($1.05M) · Sold 24,277 shares ($805K)
11 Jan 2018	Form 4/A: Portage Biotech Inc., 10% owner Sold 4,350 shares ($125K)

Comments